We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.8%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.85B
AUM Growth
+$181M
Cap. Flow
+$27.3M
Cap. Flow %
1.48%
Top 10 Hldgs %
26.18%
Holding
272
New
16
Increased
74
Reduced
154
Closed
22

Top Buys

Rank Stock Value
1
WEX icon
WEX
WEX
+$25M
2
DOX icon
Amdocs
DOX
+$10.9M
3
ETSY icon
Etsy
ETSY
+$9.39M
4
GNTX icon
Gentex
GNTX
+$8.86M
5
MGPI icon
MGP Ingredients
MGPI
+$6.5M

Top Sells

Rank Stock Value
1
AX icon
Axos Financial
AX
+$16.8M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.5M
3
ADMA icon
ADMA Biologics
ADMA
+$11.5M
4
ACIW icon
ACI Worldwide
ACIW
+$9.89M
5
RXO icon
RXO
RXO
+$8.37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.6%
2 Technology 28.67%
3 Industrials 15.74%
4 Consumer Staples 6.67%
5 Communication Services 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CW icon
201
Curtiss-Wright
CW
$25.4B
$1.28M 0.07%
3,897
-88
-2% -$26K
BRK.B icon
202
Berkshire Hathaway Class B
BRK.B
$1.15T
$1.21M 0.07%
2,625
-175
-6% -$77.4K
VREX icon
203
Varex Imaging
VREX
$777M
$1.15M 0.06%
+96,463
New +$1.23M
TBRG
204
DELISTED
TruBridge
TBRG
$1.14M 0.06%
95,594
+12,227
+15% +$142K
AIOT
205
PowerFleet Inc
AIOT
$419M
$1.14M 0.06%
+227,263
New +$1.08M
DOV icon
206
Dover
DOV
$28.4B
$1.13M 0.06%
5,891
-124
-2% -$22.6K
VMC icon
207
Vulcan Materials
VMC
$36.8B
$1.12M 0.06%
4,477
-108
-2% -$26.8K
ABBV icon
208
AbbVie
ABBV
$434B
$930K 0.05%
4,707
-20
-0.4% -$3.73K
PGNY icon
209
Progyny
PGNY
$2.26B
$803K 0.04%
47,919
-27,500
-36% -$660K
TECH icon
210
Bio-Techne
TECH
$11.3B
$801K 0.04%
10,024
-214
-2% -$16.1K
TDY icon
211
Teledyne Technologies
TDY
$32.1B
$781K 0.04%
1,784
+120
+7% +$49.8K
OPTN
212
DELISTED
OptiNose
OPTN
$764K 0.04%
76,042
+10,163
+15% +$148K
CR icon
213
Crane Co
CR
$12.7B
$755K 0.04%
4,767
-160
-3% -$24.1K
BMRN icon
214
BioMarin Pharmaceuticals
BMRN
$12.5B
$726K 0.04%
10,327
-10,352
-50% -$865K
IEX icon
215
IDEX
IEX
$17.3B
$721K 0.04%
3,362
-81
-2% -$16.3K
BRKR icon
216
Bruker
BRKR
$8.5B
$705K 0.04%
10,215
-255
-2% -$16.5K
BRK.A icon
217
Berkshire Hathaway Class A
BRK.A
$1.15T
$691K 0.04%
1
KEX icon
218
Kirby Corp
KEX
$6.96B
$685K 0.04%
5,599
-171
-3% -$20.4K
CDW icon
219
CDW
CDW
$17.1B
$681K 0.04%
3,010
-6
-0.2% -$1.33K
IWO icon
220
iShares Russell 2000 Growth ETF
IWO
$14.9B
$658K 0.04%
2,316
-2,318
-50% -$635K
CIEN icon
221
Ciena
CIEN
$58B
$625K 0.03%
10,150
-248
-2% -$13.1K
EBAY icon
222
eBay
EBAY
$47.5B
$608K 0.03%
9,338
-181
-2% -$10.4K
DENN
223
DELISTED
Denny's
DENN
$603K 0.03%
93,440
+17,430
+23% +$114K
AAPL icon
224
Apple
AAPL
$4.47T
$585K 0.03%
2,510
ABT icon
225
Abbott
ABT
$187B
$571K 0.03%
5,008
-38
-0.8% -$4.17K

Similar funds

Rice Hall James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Rice Hall James & Associates held 272 positions worth $1.85B, up 11% from $1.67B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2024 filing shows 16 new, 74 increased, 154 reduced and 22 closed positions. Its largest new stake was Gentex: 285,297 shares worth $8.47M. The largest sale was Axos Financial, an estimated $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2024 buy was Gentex: 285,297 shares worth $8.47M.
  • Rice Hall James & Associates added most to WEX in Q3 2024, an estimated $25M increase.
  • Rice Hall James & Associates's biggest Q3 2024 reduction was Axos Financial, cutting an estimated $16.8M.
  • Rice Hall James & Associates fully exited RXO in Q3 2024, selling an estimated $8.37M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.85B portfolio in Q3 2024.
  • Rice Hall James & Associates opened 16 new positions and closed 22 in Q3 2024.
  • Rice Hall James & Associates's portfolio value rose 11% quarter-over-quarter to $1.85B.

Based on Rice Hall James & Associates's 13F filing for Q3 2024, filed 28 Oct 2024.